Latest Schedule 13D activist filings

Robert Gregory Kidd and Goldeneye 1995 LLC have acquired a controlling 93.1% stake in Know Labs, Inc. through a private placement.

WideOpenWest, Inc. has entered into a definitive merger agreement to be acquired and taken private by a consortium led by Crestview Partners and DigitalBridge Investments for $5.20 per share in cash.

Andrew Dudum, CEO of Hims & Hers Health, Inc., has updated his beneficial ownership to 10.3% of the Class A common stock, reflecting a significant insider stake.

V2X's largest shareholder, Vertex Holdco, sold 2 million shares, leading to reduced board representation and loss of key consent rights.

OrbiMed Advisors and affiliated entities reported a decrease in their beneficial ownership of ArriVent BioPharma, Inc. common stock to 7.5% due to an increase in the issuer's outstanding shares.

Versant Venture Capital funds filed an amended Schedule 13D, updating their beneficial ownership in Tempest Therapeutics, Inc. due to dilution from recent share sales.

EverQuote, Inc. repurchased 900,000 shares of Class A Common Stock from Link Ventures LLLP for $20.997 million, with key holders entering a 180-day lock-up agreement.

Casdin Capital, a key investor, has increased its beneficial ownership in BioLife Solutions, Inc. to 15.0% through a recent share acquisition.

Christina Byland has significantly increased her beneficial ownership in RedCloud Holdings plc to 40.95% through a private placement.

Nikolaus Senn, a RedCloud Holdings plc board member, increased beneficial ownership to 12.28% through a $600,000 private placement purchase.

GSK plc's subsidiary, Glaxo Group Limited, has agreed to tender its 7.4% stake in CureVac N.V. into BioNTech SE's exchange offer.

GSK plc's subsidiary, Glaxo Group Limited, has agreed to tender its 7.4% stake in CureVac N.V. into BioNTech SE's exchange offer.

Public Sector Pension Investment Board increased its beneficial ownership in GoHealth, Inc. to 10.5% of Class A Common Stock as part of a refinancing transaction.

Redwood Capital Management and its affiliates acquired a 5.8% stake in GoHealth, Inc. Class A Common Stock as consideration for an amendment to the Issuer's credit agreement.

Highview Sponsor Co., LLC and its managing member David Boris have reported a 20.82% beneficial ownership stake in Highview Merger Corp., comprising founder and private placement shares, affirming their commitment to the SPAC's initial business combination.

Chauncey Lennis Thompson files Schedule 13D, reporting beneficial ownership of 8.9% of CalEthos, Inc.'s common stock through SFO IDF LLC.

Atlas Investissement SAS, linked to the Niel Family, has increased its economic exposure to Millicom International Cellular S.A. common shares through new European-style call spread option transactions with three financial institutions.

Hannover Holdings S.A. and its affiliates have reduced their beneficial ownership in Satellogic Inc. to 4.4%, falling below the 5% threshold.

William Kerber III's beneficial ownership in Nauticus Robotics, Inc. has decreased to 4.4% due to an increase in the company's outstanding shares, triggering a Schedule 13D amendment.

HX Entertainment Ltd., controlled by blockchain entrepreneur Alexandre Dreyfus, has acquired a 10.9% stake in Processa Pharmaceuticals, Inc. for investment purposes, aligning with Processa's exploration of cryptocurrency treasury strategies.

Saba Capital Management, L.P. and affiliates increased their beneficial ownership in ASA Gold and Precious Metals Limited to 21.41% through open market purchases.

Veritone's Ryan Steelberg increased his beneficial ownership to 10.9% through a private placement of 366,300 shares at $2.73 per share.

Public Sector Pension Investment Board and its subsidiary acquired a 10.5% stake in GoHealth, Inc. Class A Common Stock as part of a refinancing transaction.

BridgeBio Oncology Therapeutics, formerly Helix Acquisition Corp. II, completed its business combination with TheRas, Inc., leading to significant shareholding changes for key investors including Bihua Chen.

Innoviva, Inc. and its subsidiary have increased their beneficial ownership in Armata Pharmaceuticals to 83.3% and provided a new $15 million secured loan.

Innoviva, Inc. and its subsidiary have increased their beneficial ownership in Armata Pharmaceuticals to 83.3% and provided a new $15 million secured loan.

RumbleOn, Inc. directors William Coulter and Mark Tkach committed to provide $6.67 million in high-interest subordinated loans to prepay existing debt.

Key insiders Nathaniel Bradley and Sonia Choi adjust their beneficial ownership in Datavault AI Inc. following compensation awards and share transfers related to settlement and services agreements.

Deutsche Telekom and its subsidiaries updated their beneficial ownership in T-Mobile US, Inc., reporting a 56.5% stake amidst significant share sales by SoftBank entities and ongoing planned sales by DT Holding.

Deutsche Telekom and its subsidiaries updated their beneficial ownership in T-Mobile US, Inc., reporting a 56.5% stake amidst significant share sales by SoftBank entities and ongoing planned sales by DT Holding.